Design of an Oral Tablet Containing Furosemide Nanoparticles with Elevated Bioavailability-Reference-Cited by-同舟云学术

Design of an Oral Tablet Containing Furosemide Nanoparticles with Elevated Bioavailability

Published:2024 Issue:4 Volume:73 Page:563-571
ISSN:1345-8957
Container-title:Journal of Oleo Science
language:en
Short-container-title:J. Oleo Sci.

Author:

Nagai Noriaki¹,Ogata Fumihiko¹,Kadowaki Reita¹,Deguchi Saori¹,Otake Hiroko¹,Nakazawa Yosuke²,Misra Manju³⁴,Kawasaki Naohito¹

Affiliation:

1. Faculty of Pharmacy, Kindai University

2. Faculty of Pharmacy, Keio University

3. Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research

4. Graduate School of Pharmacy, Gujarat Technological University, Gandhinagar Campus Nr. Government Polytechnic K-6 Circle, E-4 Electronic Estate G.I.D.C

Publisher

Japan Oil Chemists' Society

Link

https://www.jstage.jst.go.jp/article/jos/73/4/73_ess23229/_pdf

Reference23 articles.

1. 1) Boles Ponto, L.L.; Schoenwald, R.D. Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). Clin. Pharmacokinet. 18, 381-408 (1990). doi: 10.2165/00003088-199018050-00004

2. 2) Lindenberg, M.; Kopp, S.; Dressman, J.B. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur. J. Pharm. Biopharm. 58, 265-278 (2004). doi: 10.1016/j.ejpb.2004.03.001

3. 3) Davis, S.S. Formulation strategies for absorption windows. Drug Discov. Today 10, 249-257 (2005). doi: 10.1016/S1359-6446 (04) 03351-3

4. 4) Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Deliv. Rev. 58, 1688-1713 (2006). doi: 10.1016/j.addr.2006.09.017

5. 5) Jog, R.; Burgess, D.J. Pharmaceutical amorphous nanoparticles. J. Pharm. Sci. 106, 39-65 (2017). doi: 10.1016/j.xphs.2016.09.014